RightFit
RecruitingNot applicable

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+): A Multi-Site Pilot Randomized Controlled Trial

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
50 Years to 80 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires, Interviews

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants will complete a baseline survey and follow-up surveys at 4 and 8 months, and researchers will review electronic health record information to determine whether lung cancer screening was discussed, ordered, and completed."
  • "Some participants will also be invited to complete a one-time interview about their experiences with the study."
  • "Data will be collected through participant surveys, electronic health record review, intervention process measures, and qualitative interviews with a subset of participants to evaluate implementation experiences."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests ways to help adults who qualify for lung cancer screening get screened. It compares usual care with extra support to a program with learning materials, reminders, resource information, and possible phone help. It is for eligible patients at UC Irvine Health or Emory Healthcare.

Lung cancer screening (LCS) with low-dose computed tomography (LDCT) can reduce the risk of dying from lung cancer, but many people who are eligible for screening do not receive it. The purpose of the Empower LCS/Call+ study is to evaluate new strategies to improve lung cancer screening among adults who are eligible for screening based on current U.S. Preventive Services Task Force (USPSTF) guidelines. This pilot randomized controlled trial will enroll approximately 80 participants from UC Irvine Health and Emory Healthcare. Participants will be randomly assigned to receive either enhanced usual care or the Empower LCS/Call+ intervention. The intervention includes educational materials, reminders for patients and primary care providers, and information about financial and community resources when appropriate. Participants who do not complete lung cancer screening after the initial intervention may receive additional telephone-based navigation through the Call+ program to help identify and address barriers to screening and help with scheduling. Participants will complete a baseline survey and follow-up surveys at 4 and 8 months, and researchers will review electronic health record information to determine whether lung cancer screening was discussed, ordered, and completed. Some participants will also be invited to complete a one-time interview about their experiences with the study. The results of this study will help determine the feasibility, acceptability, and preliminary effectiveness of the Empower LCS/Call+ intervention and will inform future efforts to improve equitable access to lung cancer screening.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be 50 to 80 years old.
  • Have smoked at least 20 pack-years, such as 1 pack a day for 20 years or 2 packs a day for 10 years.
  • Smoke now or have quit within the last 15 years.
  • Have a primary care provider at UC Irvine Health or Emory Healthcare listed in your health record.
  • Have had an office or emergency room visit, or a hospital stay ending with discharge home, in the past 12 months; or have an office visit scheduled in the next 3 months.
  • Speak English or Spanish.
  • Be able and willing to give informed consent, meaning you understand the study and agree to join.

Who can't join

  • Reach the upper age limit of 80 during the first 4 months of the study.
  • Have had lung cancer.
  • Have been newly diagnosed with another cancer in the past 12 months.
  • Have had a chest CT scan or low-dose CT scan, which takes detailed pictures of the chest, in the past 12 months.
  • Have Alzheimer's disease recorded as a diagnosis code in your electronic health record.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. Must meet current USPSTF eligibility criteria for lung cancer screening (Current criteria: age 50-80 years old with a 20 pack-year smoking history, who currently smoke or have quit within the last 15 years) 2. Must have an electronic health record-assigned primary care provider within University of California Irvine Health or Emory Healthcare 3. Must have recent engagement with respective health system (i.e., office or emergency department (ED) visit, hospitalization with discharged home in the last 12 months, or a scheduled office visit in the next 3 months). 4. Must speak English or Spanish 5. Able and willing to provide informed consent Exclusion Criteria: 1. Meet the eligibility upper age limit during initial 4-month participation. 2. Have a prior history of lung cancer. 3. Have a new diagnosis of other cancers in the 12 months 4. Have a chest CT or LDCT in the last 12 months 5. Have ICD-10 code of Alzheimer's disease in EHR

Study sites (57)

CA

GA